Sex | Modela | Treatment group | N (med/placebo) | Bb | 95%CI | P |
---|---|---|---|---|---|---|
All | Original | Metoprolol-Placebo | 118/117 | −0.09 | −0.35 to 0.17 | 0.48 |
Fluvastatin-Metoprolol | 117/117 | 0.10 | −0.13 to 0.33 | 0.38 | ||
Fluvastatin-Placebo | 120/117 | −0.04 | −0.24 to 0.17 | 0.72 | ||
Pooled | Fluvastatin | 237/235 | 0.08 | −0.09 to 0.24 | 0.24 | |
Pooled | Metoprolol | 235/237 | 0.02 | −0.14 to 0.19 | 0.80 | |
Male | Original | Metoprolol-Placebo | 40/39 | −0.17 | −0.55 to 0.21 | 0.38 |
Fluvastatin-Metoprolol | 47/39 | −0.53 | −1.02 to −0.04 | 0.03 | ||
Fluvastatin-Placebo | 48/39 | −0.15 | −0.42 to 0.11 | 0.26 | ||
Pooled | Fluvastatin | 95/79 | −0.27 | −0.54 to 0.00 | 0.05 | |
Pooled | Metoprolol | 87/87 | −0.25 | −0.52 to 0.02 | 0.07 | |
Female | Original | Metoprolol-Placebo | 78/78 | −0.07 | −0.38 to 0.25 | 0.68 |
Fluvastatin-Metoprolol | 70/78 | 0.32 | 0.06 to 0.58 | 0.02 | ||
Fluvastatin-Placebo | 72/78 | 0.03 | −0.23 to 0.28 | 0.83 | ||
Pooled | Fluvastatin | 142/156 | 0.20 | 0.00 to 0.41 | 0.05 | |
Pooled | Metoprolol | 148/150 | 0.10 | −0.10 to 0.31 | 0.33 |